TNFAIP3 and neoplasm: When bulk tumor cells were analyzed for expression of CD133 and A20, greater than 75% of CD133+ cells were also A20+, whereas less than 10% of CD133− cells were A20+ (Figure 2C; Figure S2A and 2SB).